Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 17, 2023

BUY
$31.86 - $67.26 $831,322 - $1.76 Million
26,093 Added 3540.43%
26,830 $1.15 Million
Q1 2023

May 02, 2023

BUY
$45.44 - $74.26 $33,489 - $54,729
737 New
737 $48,000
Q3 2021

Oct 25, 2021

SELL
$109.17 - $142.35 $131,440 - $171,389
-1,204 Closed
0 $0
Q2 2021

Jul 26, 2021

SELL
$100.34 - $115.69 $86,392 - $99,609
-861 Reduced 41.69%
1,204 $424,000
Q1 2021

Apr 27, 2021

BUY
$101.51 - $125.27 $43,141 - $53,239
425 Added 25.91%
2,065 $727,000
Q3 2020

Oct 20, 2020

BUY
$72.74 - $92.5 $119,293 - $151,700
1,640 New
1,640 $140,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Harel Insurance Investments & Financial Services Ltd. Portfolio

Follow Harel Insurance Investments & Financial Services Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harel Insurance Investments & Financial Services Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Harel Insurance Investments & Financial Services Ltd. with notifications on news.